These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9029744)
1. Comparative serum estradiol profiles from a new once-a-week transdermal estradiol patch and a twice-a-week transdermal estradiol patch. Harrison LI; Riedel DJ; Chang SF; Jacobson JP; Sellers JA; Kanniainen CM; Crowley JK; Hinderling PH Ther Drug Monit; 1997 Feb; 19(1):37-42. PubMed ID: 9029744 [TBL] [Abstract][Full Text] [Related]
2. Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy. Gordon SF Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 2):998-1004. PubMed ID: 7573298 [TBL] [Abstract][Full Text] [Related]
3. Comparative bioavailability study of an once-a-week matrix versus a twice-a-week reservoir transdermal estradiol delivery systems in postmenopausal women. Baracat E; Haidar M; Castelo A; Tufik S; de Lima GR; Vieira JG; Peloso U; Casoy J Maturitas; 1996 Apr; 23(3):285-91. PubMed ID: 8794422 [TBL] [Abstract][Full Text] [Related]
4. Improved patient acceptability with a transdermal drug-in-adhesive oestradiol patch. Lake Y; Pinnock S Aust N Z J Obstet Gynaecol; 2000 Aug; 40(3):313-6. PubMed ID: 11065040 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix. Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C Arzneimittelforschung; 1998 Mar; 48(3):275-85. PubMed ID: 9553686 [TBL] [Abstract][Full Text] [Related]
6. 17Beta-estradiol delivered by three different matrix patches 50 microg/day: a three way cross-over study in 21 postmenopausal women. Rohr UD; Nauert C; Stehle B Maturitas; 1999 Sep; 33(1):45-58. PubMed ID: 10585173 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol. Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276 [TBL] [Abstract][Full Text] [Related]
8. Dose proportionality study of four doses of an estradiol transdermal system, Estradot. Hossain M; Quebe-Fehling E; Sergejew T; Schmidt G; Skerjanec A; Ibarra de Palacios P; Krinsky L Maturitas; 2003 Nov; 46(3):173-85. PubMed ID: 14585520 [TBL] [Abstract][Full Text] [Related]
9. Comparison of pharmacokinetic profiles of a 17 beta-estradiol gel 0.6 mg/g (Gelestra) with a transdermal delivery system (Estraderm TTS 50) in postmenopausal women at steady state. Paoletti AM; Pilia I; Nannipieri F; Bigini C; Melis GB Maturitas; 2001 Dec; 40(3):203-9. PubMed ID: 11731181 [TBL] [Abstract][Full Text] [Related]
10. Serum Estradiol and Estrone Levels During 3 Weeks of Alternate-Site and Same-Site Applications of a Once-A-Week Drug-in-Adhesive Transdermal Estradiol Patch. Harrison LI; Riedel DJ; Reynolds SJ; Kolars CA; Chang SF; Edgren AR; Nelson JR Am J Ther; 1996 Aug; 3(8):574-579. PubMed ID: 11862293 [TBL] [Abstract][Full Text] [Related]
11. Plasma profiles of transdermal 17 beta-estradiol delivered by two different matrix patches. A four-way cross-over study in postmenopausal women. Rohr UD; Ehrly AM; Kuhl H Arzneimittelforschung; 1997 Jun; 47(6):761-7. PubMed ID: 9239456 [TBL] [Abstract][Full Text] [Related]
12. Comparative absorption and variability in absorption of estradiol from a transdermal gel and a novel matrix-type transdermal patch. Järvinen A; Bäckström A; Elfström C; Viitanen A Maturitas; 2001 Apr; 38(2):189-96. PubMed ID: 11306208 [TBL] [Abstract][Full Text] [Related]
13. New trends in transdermal technologies: development of the skin patch, Menorest. Marty JP Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S17-20. PubMed ID: 8666122 [TBL] [Abstract][Full Text] [Related]
14. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies. Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047 [TBL] [Abstract][Full Text] [Related]